The treatment of patients with low tumour burden and/or slow growing disease.
In the evaluation of the wide range of novel therapeutics which have been developed, investigators do not have to be tied to the current paradigm of demonstrating additive efficacy to first line combination therapy. The addition of new agents to FOLFOX regimens has proved a high hurdle at which many...
Үндсэн зохиолч: | Maughan, T |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2011
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
The response of fast-, medium- and slow-growing chickens to a low protein diet
-н: Darina Chodová, зэрэг
Хэвлэсэн: (2021-03-01) -
Is visual radiological evaluation of liver tumour burden in patients with neuroendocrine tumours reproducible?
-н: Magaly Zappa, зэрэг
Хэвлэсэн: (2017-02-01) -
STING signalling compensates for low tumour mutation burden to drive anti-tumour immunityResearch in context
-н: Jiayi Tan, зэрэг
Хэвлэсэн: (2024-03-01) -
Slow growing of Stieltjes integrals of monotone functions
-н: M. V. Zabolotskyj, зэрэг
Хэвлэсэн: (2013-01-01) -
Cassava residues in the diet of slow-growing broilers
-н: Silvia Silva VIEIRA, зэрэг
Хэвлэсэн: (2022-09-01)